Most Recent

image: H.M.’s Brain

H.M.’s Brain

By | May 9, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Week in Review: May 5–9

Week in Review: May 5–9

By | May 9, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Exercise Can Erase Memories

Exercise Can Erase Memories

By | May 8, 2014

Scenes from the labs that study the unique organ

7 Comments

image: Rock Snot Explained

Rock Snot Explained

By | May 8, 2014

Scenes from the labs that study the unique organ

1 Comment

image: Minis Ensure Synaptic Maturation

Minis Ensure Synaptic Maturation

By | May 7, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Finch-Powered Fumigation

Finch-Powered Fumigation

By | May 7, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Lab-Grown Primordial Sperm

Lab-Grown Primordial Sperm

By | May 2, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Week in Review: April 28–May 2

Week in Review: April 28–May 2

By | May 2, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2014

Scenes from the labs that study the unique organ

0 Comments

image: Contributors

Contributors

By and | May 1, 2014

Scenes from the labs that study the unique organ

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech